Navigation Links
Elekta's Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012's Best in KLAS for Radiation Therapy
Date:6/27/2012

ATLANTA, June 27, 2012 /PRNewswire/ -- Elekta swept the top three rankings in the KLAS research firm's recently released 2012 Best in KLAS Awards: Medical Equipment & Infrastructure report*. Elekta's Leksell Gamma Knife® Perfexion™ radiosurgery system and Elekta Synergy® and Elekta Infinity™ radiation therapy systems earned the #1, #2 and #3 rankings, respectively, out of eight possible rankings. 

In the report, Perfexion scored 93.9 out of 100, and 100 percent of customers indicated they would buy again. On a 1 to 9 scale, Perfexion received an 8.7 from respondents for satisfaction with product uptime, the highest score among all vendors rated in the market segment.

Elekta Synergy scored 87.1 out of 100, and 100 percent of customers specified they would purchase again. Elekta Infinity received a score of 85.4, with 86 percent indicating they would buy again. All three Elekta solutions posted an improved rating change from last year's KLAS report: Perfexion, +1 percent; Synergy, +1 percent; and Infinity, +4 percent.

"Once again, we're honored that the KLAS respondents continue to hold Elekta products in such high regard, and that they've been able earn even higher marks than last year," says Jay Hoey, Executive Vice President, Elekta North America. "We translate our customers' perceptions of these solutions as a reflection of how well they help improve and prolong patients' lives."

KLAS gathers opinions of thousands of healthcare professionals

The KLAS awards are based on data from customer surveys of hospital and clinic executives, administrators, physicians, nurses and other directors and managers interacting with healthcare equipment and infrastructure solutions.

According to KLAS, Best in KLAS designations go to solutions that have excelled in their respective market segments, that show the vendor's leadership in working with customers to resolve issues and match expectations to reality, and that have the broadest operational and clinical impact to healthcare organizations.

"Vendors who are recognized with a Best in KLAS award are those who have gone above and beyond their customers' expectations. The goal and the value of the awards is to ultimately help providers and the industry easily identify which vendors are consistently performing well," said Adam Gale, president of KLAS.

The 2012 Best in KLAS Awards: Medical Equipment & Infrastructure report is available online. To purchase the full report, visit www.KLASresearch.com/BestinKLAS.

*2012 Best in KLAS Awards: Medical Equipment & Infrastructure," June, 2012. © 2012 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com

For further information, please contact:

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

 


'/>"/>
SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InterMune to Divest Actimmune® (Interferon Gamma-1b)
2. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
3. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
4. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
5. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
6. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
7. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
8. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
9. ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
10. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
11. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... VANCOUVER, British Columbia , March 23, 2017 /PRNewswire/ ... "Company" or "Sophiris"), a clinical late-stage biopharmaceutical company developing ... announced that data from its successful Phase 2a study ... treatment for localized prostate cancer, will be presented as ... nd Annual European Association of Urology in ...
(Date:3/23/2017)... 2017  Ethicon* today announced the completion of ... held medical device company that manufactures and markets ... treatment of Gastroesophageal Reflux Disease (GERD). This acquisition ... portfolio of minimally invasive options for patients suffering ... of the transaction have not been disclosed. ...
(Date:3/23/2017)... LITTLE SILVER, N.J. , March 23, 2017 ... device company, today announced that it has kicked ... in-growth into their 3D printed bone segments. ... of Engineering, "Our unique variable honeycomb lattice structures ... bone in-growth as compared to current allograft wedges ...
Breaking Medicine Technology:
(Date:3/23/2017)... New York, NY (PRWEB) , ... March 23, 2017 , ... 82% of adults are ... every 3 kids do not brush their teeth the minimum two times a day that ... teeth; with students missing 51 million hours of school and adults missing 164 million hours ...
(Date:3/23/2017)... Los Angeles, CA (PRWEB) , ... March 23, ... ... Series A funding investment in Los Angeles based healthcare technology company California Healthcom ... group’s portfolio into the US, and healthcare arena. With headquarters in California, CHG ...
(Date:3/23/2017)... ... 2017 , ... After raising more than $1.135 million ($1,479,231 AUD) from nearly ... in crowdfunding history, has established a U.S. Headquarters in New York City, FaceCradle ... , “We’re excited to be operating on U.S. shores, where most of our initial ...
(Date:3/23/2017)... ... 23, 2017 , ... According to the National Sleep Foundation , poor ... the only cause of the sunken-eye look, which can include dark circles or bags ... poor health are likely due to genetics, dehydration, allergies, and losing fat beneath the ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance ... Anniversary of ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , ... only to the association, but also to the Health Care Quality and Patient Safety ...
Breaking Medicine News(10 mins):